Clinical trial
A Long-term Follow-up Study to Evaluate the Safety and Efficacy of RCT-01 in Men and Women With Unilateral, Chronic Achilles Tendinosis
NCT02655042 is registered in ClinicalTrials.gov with RepliCel Life Sciences, Inc. as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Long-term Follow-up Study to Evaluate the Safety and Efficacy of RCT-01 in Men and Women With Unilateral, Chronic Achilles Tendinosis
- Lead sponsor
- RepliCel Life Sciences, Inc.
- Phase
- Observational
- Overall status
- Withdrawn
- Start date
- Not reported
- Completion date
- August 31, 2018
- Enrollment
- 0 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
tendinopathy, tendinosis